sulfonamide
Jump to navigation
Jump to search
Introduction
Any drug with a sulfonamide component. There are 3 basic types:
Classification
- sulfonylarylamines,
- the sulfonamide antibiotics plus some HIV protease inhibitors
- ~3% of patients report an allergy to sulfa antibiotics.
- nonsulfonylarylamines:
- sulfonamide moieties:
- contain a sulfa group not directly attached to an aromatic ring like the others
- sumatriptan, sotalol, topiramate
Adverse effects
- hypersensitivity*[2]
- use during pregnancy associated with birth defects, including:
- anencephaly
- left-sided heart defects
* PEN-FAST (SULF-FAST) criteria for predicting sulfonamide hypersensitivity
- allergic event occurred <+ 5 years ago (2 points)
- event was anaphylaxis/angioedema or severe cutaneous adverse reaction (2 points)
- treatment was required for allergic event (1 point)
* a PEN-FAST (SULF-FAST) of <3 associated with <5% risk of hypersensitivity reaction
- a score >= 3 associated with >20% risk of hypersensitivity reaction[2]
More general terms
More specific terms
- acetazolamide (Diamox)
- benzolamide
- bumetanide (Bumex)
- celecoxib (Celebrex)
- chloramine T (sulfonechloramide, Cloraseptine, Chloralone)
- chlorthalidone (Hygroton)
- clopamide (Brinaldix, Aquex)
- dapsone (Avlosulfon)
- dichlorphenamide (Daranide)
- dorzolamide (Trusopt)
- hydrochlorothiazide (HCTZ, HydroDIURIL, Oretic, Esidrix)
- mafenide (Sulfamylon)
- mefruside (Baycaron)
- methazolamide (Neptazane)
- metolazone (Zaroxolyn, Diulo, Mykrox)
- naratriptan (Amerge)
- probenecid (Benemid, Probalan)
- salicylazosulfapyridine
- sulfabenzamide
- sulfamethizole (Thiosulfil Forte, Tija, Urobiotic)
- sulfanilamide
- sumatriptan (Imitrex, migratriptan, Arcoiran, Sumavel DosePro)
- tipranavir (Aptivus, TPV)
- valdecoxib (Bextra)
- xipamide (Aquaphor, Diurexan)
- zonisamide (Zonegran)
Additional terms
References
- ↑ Prescriber's Letter 11(7):42 2004 Sulfa Drugs and the Sulfa-allergic Patient Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=211113&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 2.0 2.1 2.2 Waldron JL et al. Development and validation of a sulfa antibiotic allergy clinical decision rule. JAMA Netw Open 2023 Jun 5; 6:e2316776. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37273210 PMCID: PMC10242418 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805577